Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Axsome Therapeutics
Business Segments
Products & Services
Business Combination Consideration Transferred1
Business Combination Consideration Transferred1
Axsome Therapeutics
·
Products & Services
·
1 segment
·
Rolls up to
Business Combination Consideration Transferred1
Breakdown
Segments
Balipodect
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
Balipodect
$10.4M
Total
—